The synergistic effect of SLC6A13 and ASCL1 in regulating inflammasomes (NALP1, AIM2, NLRP3, NLRC4) and inflammatory factors (IL-1β) highlighted their important role in the pathogenesis and progression of HCC. Here, SLC6A13 is linked to hepatocellular carcinoma.